<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03861195</url>
  </required_header>
  <id_info>
    <org_study_id>MT_SOS I</org_study_id>
    <nct_id>NCT03861195</nct_id>
  </id_info>
  <brief_title>Comparative Prospective Data Collection in Connection With Two Different Treatment Methods: Robotic Assisted Laparoscopy and Conventional Laparoscopy</brief_title>
  <official_title>Comparative Prospective Data Collection in Connection With Two Different Treatment Methods: Robotic Assisted Laparoscopy and Conventional Laparoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, single-center, observational clinical trial at the
      Department of Women's Health of the University Clinic Tübingen. Four hundred patients
      affected by uterine diseases that undergo treatment with robotic assisted laparoscopic
      procedures using the Da Vinci Robotic Surgical System (200 patients) or conventional
      laparoscopic surgery (200 patients) will be recruited. In addition retrospective data of 200
      patients that underwent conventional laparoscopic surgery in the past will be documented. At
      the end of patient recruitment, surgical procedure times, the technical limits encountered,
      estimated blood loss, intra- and post-operative complications and the percentage of
      conversions from the robotic assisted treatment /conventional laparoscopic surgery to
      multiple access and/or to a laparotomic (open) approach will be documented.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>operative time</measure>
    <time_frame>60 minutes</time_frame>
    <description>(minutes from first incision to skin closure)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>time under narcosis</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>console time</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>estimated blood loss (milliliters)</measure>
    <time_frame>60 minutes</time_frame>
    <description>using the following formula: ((Hemoglobin concentration preoperative (g/l)) − (Hemoglobin 1st day postoperative (g/l)))/((Hemoglobin preoperative (g/l)) − (Hemoglobin 1st day postoperative (g/l)))/2) × 1000</description>
  </primary_outcome>
  <primary_outcome>
    <measure>conversion to other surgical procedures</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>time to discharge</measure>
    <time_frame>60 minutes</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>intraoperative complications</measure>
    <time_frame>60 minutes</time_frame>
    <description>occurring during the surgical procedure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>perioperative complications</measure>
    <time_frame>24 hours</time_frame>
    <description>occurring less than 24h after the surgical procedure, according to the Clavien-Dindo classification of surgical complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>postoperative complications</measure>
    <time_frame>6 months</time_frame>
    <description>occurring more than 24h after the surgical procedure up to 6 months after surgical procedure, according to the Clavien-Dindo classification of surgical complications</description>
  </primary_outcome>
  <primary_outcome>
    <measure>German version of the Short Form-36health survey questionnaire Medical Outcomes Trust</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>Medical Outcomes Trust: SF-36 is a set of generic, coherent, and easily administered quality-of-life measures. These measures rely upon patient self-reporting.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>German version of the female sexual function index (FSFI) questionnaire</measure>
    <time_frame>3 and 6 months</time_frame>
    <description>female sexual function index: a multidimensional self-report instrument for the assessment of female sexual function</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Uterine Diseases</condition>
  <arm_group>
    <arm_group_label>Da Vinci Robotic Surgical System</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>conventional laparoscopic surgery</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>laparoscopic surgery</intervention_name>
    <description>patients affected by uterine diseases that undergo treatment</description>
    <arm_group_label>Da Vinci Robotic Surgical System</arm_group_label>
    <arm_group_label>conventional laparoscopic surgery</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        primary care clinic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age ≥18 years

          -  BMI ≤40 kg/m2

          -  indication for hysterectomy for benign disease or prophylactic surgery due to
             hereditary cancer

          -  indication for radical hysterectomy and/or pelvic-/para-aortic (sentinel-node)
             lymphadenectomy for cervical cancer

          -  indication for modified radical hysterectomy and/or pelvic-/para-aortic
             (sentinel-node) lymphadenectomy for endometrial cancer

          -  size of uterus and vagina allows for retrieval by the vaginal route in cancer patients

          -  written informed consent

        Exclusion Criteria:

          -  known extensive intra-abdominal adhesions

          -  anaesthesiological contraindications to laparoscopy

          -  women with pacemaker or other implants where electrosurgery is to be avoided

          -  women with known defects of the hemostasis

          -  pregnancy

          -  other internal or anatomical criteria that preclude a minimal invasive approach

          -  inability to understand patient information
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sara Brucker, MD</last_name>
    <phone>+49 7071 29 82211</phone>
    <email>sasara.brucker@med.uni-tuebingen.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Bernhard Krämer, MD</last_name>
    <phone>+49 7071 29 82211</phone>
    <email>bernhard.kraemer@med.uni-tuebingen.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Tuebingen, Department of Women's Health</name>
      <address>
        <city>Tuebingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miriam Linneweh, Dr</last_name>
      <phone>+4970712982211</phone>
      <email>miriam.linneweh@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 21, 2019</study_first_submitted>
  <study_first_submitted_qc>February 28, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 4, 2019</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 17, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Uterine Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

